Sabby Management, LLC Citius Pharmaceuticals, Inc. Transaction History

Sabby Management, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.38 - $1.89 $42,590 - $58,331	-30,863 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.51 - $2.2 $46,603 - $67,898	30,863 New	30,863 $48,000
Q2 2021 Aug 16, 2021	SELL	$1.51 - $4.23 $474,140 - $1.33 Million	-314,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.04 - $2.34 $326,560 - $734,760	314,000 New	314,000 $559,000
Q4 2020 Feb 16, 2021	SELL	$0.9 - $1.2 $79,839 - $106,453	-88,711 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.83 - $1.51 $73,630 - $133,953	88,711 New	88,711 $92,000
Q2 2020 Aug 14, 2020	SELL	$0.65 - $1.45 $880,278 - $1.96 Million	-1,354,275 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.46 - $1.3 $622,966 - $1.76 Million	1,354,275 New	1,354,275 $813,000
Q4 2019 Feb 14, 2020	SELL	$0.42 - $1.15 $355,081 - $972,246	-845,432 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$0.72 - $1.38 $608,711 - $1.17 Million	845,432 New	845,432 $640,000
Q1 2019 May 15, 2019	SELL	$0.86 - $1.53 $24,118 - $42,908	-28,045 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$0.99 - $1.89 $16,316 - $31,149	16,481 Added 142.52%	28,045 $29,000
Q3 2018 Nov 14, 2018	SELL	$1.14 - $3.09 $451,002 - $1.22 Million	-395,616 Reduced 97.16%	11,564 $20,000
Q2 2018 Aug 14, 2018	SELL	$2.14 - $3.12 $500,804 - $730,145	-234,021 Reduced 36.5%	407,180 $937,000
Q1 2018 May 15, 2018	BUY	$2.84 - $4.46 $1.22 Million - $1.92 Million	431,070 Added 205.14%	641,201 $1.99 Million
Q4 2017 Feb 14, 2018	BUY	$2.65 - $5.1 $556,847 - $1.07 Million	210,131	210,131 $820,000

23.7M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $380M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.